De Groot PG - Search Results

1

Risk factors for thrombosis in lupus patients.

Hasselaar P, Derksen RH, Blokzijl L, Hessing M, Nieuwenhuis HK, Bouma BN, De Groot PG. Hasselaar P, et al. Among authors: de groot pg. Ann Rheum Dis. 1989 Nov;48(11):933-40. doi: 10.1136/ard.48.11.933. Ann Rheum Dis. 1989. PMID: 2512863 Free PMC article.

2

Lupus anticoagulant activity is frequently dependent on the presence of beta 2-glycoprotein I.

Oosting JD, Derksen RH, Entjes HT, Bouma BN, de Groot PG. Oosting JD, et al. Among authors: de groot pg. Thromb Haemost. 1992 May 4;67(5):499-502. Thromb Haemost. 1992. PMID: 1519207

3

Prospective study of fluctuations of lupus anticoagulant activity and anticardiolipin antibody titre in patients with systemic lupus erythematosus.

Out HJ, van Vliet M, de Groot PG, Derksen RH. Out HJ, et al. Among authors: de groot pg. Ann Rheum Dis. 1992 Mar;51(3):353-7. doi: 10.1136/ard.51.3.353. Ann Rheum Dis. 1992. PMID: 1575581 Free PMC article.

4

Prevalence of antiphospholipid antibodies in patients with fetal loss.

Out HJ, Bruinse HW, Christiaens GC, van Vliet M, Meilof JF, de Groot PG, Smeenk RJ, Derksen RH. Out HJ, et al. Among authors: de groot pg. Ann Rheum Dis. 1991 Aug;50(8):553-7. doi: 10.1136/ard.50.8.553. Ann Rheum Dis. 1991. PMID: 1888196 Free PMC article.

5

Antibodies to platelets in patients with anti-phospholipid antibodies.

Out HJ, de Groot PG, van Vliet M, de Gast GC, Nieuwenhuis HK, Derksen RH. Out HJ, et al. Among authors: de groot pg, de gast gc. Blood. 1991 Jun 15;77(12):2655-9. Blood. 1991. PMID: 2043767 Free article.

6

Crossreactivity of antibodies directed against cardiolipin, DNA, endothelial cells and blood platelets.

Hasselaar P, Derksen RH, Blokzijl L, de Groot PG. Hasselaar P, et al. Among authors: de groot pg. Thromb Haemost. 1990 Apr 12;63(2):169-73. Thromb Haemost. 1990. PMID: 2114042

7

Synergistic effect of low doses of tumor necrosis factor and sera from patients with systemic lupus erythematosus on the expression of procoagulant activity by cultured endothelial cells.

Hasselaar P, Derksen RH, Oosting JD, Blokzijl L, de Groot PG. Hasselaar P, et al. Among authors: de groot pg. Thromb Haemost. 1989 Sep 29;62(2):654-60. Thromb Haemost. 1989. PMID: 2510346

8

Fluctuations of anticardiolipin antibody levels in patients with systemic lupus erythematosus: a prospective study.

Out HJ, de Groot PG, Hasselaar P, dan Vliet M, Derksen RH. Out HJ, et al. Among authors: de groot pg. Ann Rheum Dis. 1989 Dec;48(12):1023-8. doi: 10.1136/ard.48.12.1023. Ann Rheum Dis. 1989. PMID: 2619354 Free PMC article.

9

Thrombosis associated with antiphospholipid antibodies cannot be explained by effects on endothelial and platelet prostanoid synthesis.

Hasselaar P, Derksen RH, Blokzijl L, de Groot PG. Hasselaar P, et al. Among authors: de groot pg. Thromb Haemost. 1988 Feb 25;59(1):80-5. Thromb Haemost. 1988. PMID: 3129812

10

Coagulation screen is more specific than the anticardiolipin antibody ELISA in defining a thrombotic subset of lupus patients.

Derksen RH, Hasselaar P, Blokzijl L, Gmelig Meyling FH, De Groot PG. Derksen RH, et al. Among authors: de groot pg. Ann Rheum Dis. 1988 May;47(5):364-71. doi: 10.1136/ard.47.5.364. Ann Rheum Dis. 1988. PMID: 3133992 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

518 results

Search Page